L
Lucid Diagnostics Inc
NASDAQ:LUCD
Lucid Diagnostics Inc
NASDAQ:LUCD
Price:
0.93 USD
2.76%
Market Closed
Updated:
May 21, 2024
Lucid Diagnostics Inc
EPS (Diluted)
|
Lucid Diagnostics Inc
EPS (Diluted) Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
L
|
Lucid Diagnostics Inc
NASDAQ:LUCD
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-79%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$4
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
105%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$5
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Lucid Diagnostics Inc's EPS (Diluted)?
EPS (Diluted)
-1.3
USD
-1.3
USD
Based on the financial report for Dec 31, 2023, Lucid Diagnostics Inc's EPS (Diluted) amounts to -1.3 USD.
What is Lucid Diagnostics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-79%
-79%
Over the last year, the EPS (Diluted) growth was 19%. The average annual EPS (Diluted) growth rates for Lucid Diagnostics Inc have been -79% over the past three years .
You don't have any saved screeners yet
